Tenaya Historical Balance Sheet

TNYA Stock

USD 1.03 0.08 7.21%

Trend analysis of Tenaya Therapeutics balance sheet accounts such as Other Liabilities of 194.9 K, Net Tangible Assets of 293.9 M, Property Plant And Equipment Net of 43.4 M or Accounts Payable of 6.1 M provides information on Tenaya Therapeutics' total assets, liabilities, and equity, which is the actual value of Tenaya Therapeutics to its prevalent stockholders. By breaking down trends over time using Tenaya Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Tenaya Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Tenaya Therapeutics is a good buy for the upcoming year.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.

About Tenaya Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Tenaya Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Tenaya Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tenaya Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tenaya currently owns. An asset can also be divided into two categories, current and non-current.

Tenaya Therapeutics Balance Sheet Chart

At present, Tenaya Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 293.9 M, whereas Other Current Liabilities is forecasted to decline to about 7.5 M.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Other Liab

Add Fundamental

Total Assets

Total assets refers to the total amount of Tenaya Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Tenaya Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Tenaya Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Tenaya Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from Tenaya Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Tenaya Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenaya Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.At present, Tenaya Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 293.9 M, whereas Other Current Liabilities is forecasted to decline to about 7.5 M.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	6.7M	12.8M	14.7M	7.5M
Total Assets	278.9M	170.5M	196.1M	209.0M

Other Current Liab Total Assets

Tenaya Therapeutics balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		0.64	0.9	0.93	-0.93	0.89	0.93	-0.43	-0.75	0.97	0.62	0.92	0.84	0.63	0.99	0.41	0.9	-0.47	0.93	0.86	0.17	0.93	0.85	0.99	0.77	0.98
Other Current Liab	0.64		0.88	0.71	-0.84	0.83	0.85	-0.1	-0.91	0.67	0.28	0.8	0.94	-0.04	0.53	0.96	0.52	-0.6	0.75	0.91	-0.29	0.71	0.91	0.56	0.17	0.5
Total Current Liabilities	0.9	0.88		0.95	-0.98	0.97	1.0	-0.21	-0.91	0.94	0.43	0.98	0.99	0.4	0.82	0.72	0.79	-0.7	0.97	1.0	-0.04	0.95	0.99	0.83	0.58	0.79
Total Stockholder Equity	0.93	0.71	0.95		-0.94	0.94	0.95	-0.11	-0.77	0.99	0.33	0.95	0.9	0.61	0.89	0.49	0.92	-0.74	0.97	0.93	-0.02	1.0	0.89	0.89	0.79	0.86
Other Liab	-0.93	-0.84	-0.98	-0.94		-0.98	-0.98	0.26	0.93	-0.94	-0.51	-0.97	-0.96	-0.38	-0.88	-0.67	-0.82	0.66	-0.96	-0.96	0.05	-0.94	-0.96	-0.88	-0.57	-0.85
Net Tangible Assets	0.89	0.83	0.97	0.94	-0.98		0.96	-0.09	-0.91	0.93	0.36	0.94	0.95	0.35	0.82	0.67	0.83	-0.77	0.94	0.96	-0.18	0.94	0.94	0.83	0.56	0.79
Property Plant And Equipment Net	0.93	0.85	1.0	0.95	-0.98	0.96		-0.27	-0.9	0.95	0.49	0.99	0.98	0.45	0.86	0.68	0.81	-0.66	0.98	0.99	0.03	0.95	0.98	0.87	0.62	0.83
Net Debt	-0.43	-0.1	-0.21	-0.11	0.26	-0.09	-0.27		0.23	-0.21	-0.95	-0.31	-0.18	-0.29	-0.47	-0.03	-0.05	-0.49	-0.27	-0.18	-0.78	-0.11	-0.25	-0.45	-0.18	-0.47
Retained Earnings	-0.75	-0.91	-0.91	-0.77	0.93	-0.91	-0.9	0.23		-0.76	-0.46	-0.89	-0.94	-0.07	-0.65	-0.84	-0.56	0.64	-0.85	-0.93	0.12	-0.77	-0.95	-0.67	-0.25	-0.62
Accounts Payable	0.97	0.67	0.94	0.99	-0.94	0.93	0.95	-0.21	-0.76		0.43	0.95	0.88	0.65	0.94	0.45	0.93	-0.66	0.97	0.91	0.05	0.99	0.88	0.94	0.81	0.91
Cash	0.62	0.28	0.43	0.33	-0.51	0.36	0.49	-0.95	-0.46	0.43		0.53	0.39	0.32	0.65	0.19	0.26	0.25	0.49	0.4	0.65	0.33	0.46	0.64	0.27	0.65
Non Current Assets Total	0.92	0.8	0.98	0.95	-0.97	0.94	0.99	-0.31	-0.89	0.95	0.53		0.95	0.51	0.86	0.63	0.78	-0.65	1.0	0.97	0.13	0.95	0.97	0.86	0.64	0.82
Non Currrent Assets Other	0.84	0.94	0.99	0.9	-0.96	0.95	0.98	-0.18	-0.94	0.88	0.39	0.95		0.28	0.75	0.81	0.72	-0.69	0.93	1.0	-0.1	0.9	0.99	0.76	0.47	0.71
Other Assets	0.63	-0.04	0.4	0.61	-0.38	0.35	0.45	-0.29	-0.07	0.65	0.32	0.51	0.28		0.68	-0.29	0.65	-0.21	0.57	0.35	0.54	0.61	0.32	0.65	0.95	0.66
Cash And Short Term Investments	0.99	0.53	0.82	0.89	-0.88	0.82	0.86	-0.47	-0.65	0.94	0.65	0.86	0.75	0.68		0.29	0.9	-0.38	0.87	0.78	0.22	0.89	0.77	1.0	0.8	1.0
Common Stock Shares Outstanding	0.41	0.96	0.72	0.49	-0.67	0.67	0.68	-0.03	-0.84	0.45	0.19	0.63	0.81	-0.29	0.29		0.27	-0.51	0.56	0.77	-0.35	0.49	0.79	0.32	-0.1	0.26
Short Term Investments	0.9	0.52	0.79	0.92	-0.82	0.83	0.81	-0.05	-0.56	0.93	0.26	0.78	0.72	0.65	0.9	0.27		-0.6	0.81	0.75	-0.13	0.92	0.7	0.91	0.85	0.9
Non Current Liabilities Total	-0.47	-0.6	-0.7	-0.74	0.66	-0.77	-0.66	-0.49	0.64	-0.66	0.25	-0.65	-0.69	-0.21	-0.38	-0.51	-0.6		-0.68	-0.71	0.45	-0.74	-0.66	-0.38	-0.4	-0.33
Other Current Assets	0.93	0.75	0.97	0.97	-0.96	0.94	0.98	-0.27	-0.85	0.97	0.49	1.0	0.93	0.57	0.87	0.56	0.81	-0.68		0.96	0.13	0.97	0.95	0.87	0.7	0.83
Other Stockholder Equity	0.86	0.91	1.0	0.93	-0.96	0.96	0.99	-0.18	-0.93	0.91	0.4	0.97	1.0	0.35	0.78	0.77	0.75	-0.71	0.96		-0.07	0.93	0.99	0.79	0.53	0.74
Total Liab	0.17	-0.29	-0.04	-0.02	0.05	-0.18	0.03	-0.78	0.12	0.05	0.65	0.13	-0.1	0.54	0.22	-0.35	-0.13	0.45	0.13	-0.07		-0.02	-0.01	0.18	0.3	0.2
Net Invested Capital	0.93	0.71	0.95	1.0	-0.94	0.94	0.95	-0.11	-0.77	0.99	0.33	0.95	0.9	0.61	0.89	0.49	0.92	-0.74	0.97	0.93	-0.02		0.89	0.89	0.79	0.86
Property Plant And Equipment Gross	0.85	0.91	0.99	0.89	-0.96	0.94	0.98	-0.25	-0.95	0.88	0.46	0.97	0.99	0.32	0.77	0.79	0.7	-0.66	0.95	0.99	-0.01	0.89		0.77	0.49	0.73
Total Current Assets	0.99	0.56	0.83	0.89	-0.88	0.83	0.87	-0.45	-0.67	0.94	0.64	0.86	0.76	0.65	1.0	0.32	0.91	-0.38	0.87	0.79	0.18	0.89	0.77		0.79	1.0
Non Current Liabilities Other	0.77	0.17	0.58	0.79	-0.57	0.56	0.62	-0.18	-0.25	0.81	0.27	0.64	0.47	0.95	0.8	-0.1	0.85	-0.4	0.7	0.53	0.3	0.79	0.49	0.79		0.8
Net Working Capital	0.98	0.5	0.79	0.86	-0.85	0.79	0.83	-0.47	-0.62	0.91	0.65	0.82	0.71	0.66	1.0	0.26	0.9	-0.33	0.83	0.74	0.2	0.86	0.73	1.0	0.8

Click cells to compare fundamentals

Tenaya Therapeutics Account Relationship Matchups

Tenaya Therapeutics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	148.2M	314.2M	278.9M	170.5M	196.1M	209.0M
Other Current Liab	4.0M	7.1M	6.7M	12.8M	14.7M	7.5M
Total Current Liabilities	5.0M	21.8M	24.2M	22.7M	26.1M	17.1M
Total Stockholder Equity	(81.3M)	278.5M	243.4M	139.4M	160.3M	118.0M
Property Plant And Equipment Net	17.2M	54.7M	62.7M	53.3M	61.2M	43.4M
Net Debt	(128.5M)	(24.4M)	(80.2M)	(33.3M)	(38.2M)	(40.2M)
Retained Earnings	(82.8M)	(155.5M)	(279.2M)	(403.3M)	(363.0M)	(344.8M)
Accounts Payable	1.0M	10.7M	9.6M	5.6M	6.5M	6.1M
Cash	128.5M	38.1M	95.3M	45.7M	52.5M	72.9M
Non Current Assets Total	18.2M	58.8M	85.2M	58.9M	67.8M	50.9M
Non Currrent Assets Other	378K	4.1M	4.8M	5.7M	6.5M	3.3M
Other Assets	1.0M	4.1M	4.8M	1.0	1.15	1.09
Cash And Short Term Investments	128.5M	251.3M	204.2M	104.6M	120.3M	157.4M
Short Term Investments	0.0	213.2M	91.3M	59.0M	67.8M	80.6M
Liabilities And Stockholders Equity	148.2M	314.2M	278.9M	170.5M	196.1M	209.0M
Non Current Liabilities Total	224.4M	13.9M	11.3M	8.4M	7.5M	7.1M
Other Current Assets	1.4M	8.1M	11.3M	6.9M	8.0M	6.4M
Other Stockholder Equity	1.6M	434.2M	522.9M	542.8M	624.2M	330.5M
Total Liab	229.5M	35.7M	278.9M	31.1M	28.0M	26.6M
Net Invested Capital	(81.3M)	278.5M	243.4M	139.4M	160.3M	118.0M
Property Plant And Equipment Gross	17.2M	54.7M	78.4M	77.6M	89.2M	52.2M
Total Current Assets	130.0M	255.4M	193.8M	111.6M	128.3M	158.0M
Accumulated Other Comprehensive Income	(221.8K)	(141K)	(378K)	(106K)	(95.4K)	(100.2K)
Non Current Liabilities Other	19K	13.9M	11.3M	253K	291.0K	276.4K
Net Working Capital	124.9M	233.6M	169.5M	88.8M	102.2M	140.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether Tenaya Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenaya Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenaya Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenaya Therapeutics Stock:

How To Invest In Tenaya

Details

Is Tenaya Stock a good investment?

Details

What is Tenaya Therapeutics' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Tenaya Stock refer to our How to Trade Tenaya Stock guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenaya Therapeutics. If investors know Tenaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenaya Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.44)

Return On Assets

(0.46)

Return On Equity

(0.84)

The market value of Tenaya Therapeutics is measured differently than its book value, which is the value of Tenaya that is recorded on the company's balance sheet. Investors also form their own opinion of Tenaya Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenaya Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenaya Therapeutics' market value can be influenced by many factors that don't directly affect Tenaya Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tenaya Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenaya Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenaya Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tenaya Historical Balance Sheet

About Tenaya Balance Sheet Analysis

Tenaya Therapeutics Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Tenaya Therapeutics balance sheet Correlations

Tenaya Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Tenaya Therapeutics balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Total Current Liabilities
Other Stockholder Equity	+ 1.0	Total Current Liabilities
Net Invested Capital	+ 1.0	Total Stockholder Equity
Other Current Assets	+ 1.0	Non Current Assets Total
Other Stockholder Equity	+ 1.0	Non Currrent Assets Other
Total Current Assets	+ 1.0	Cash And Short Term Investments

Property Plant And Equipment Net	- 0.98	Other Liab
Net Tangible Assets	- 0.98	Other Liab
Other Liab	- 0.98	Total Current Liabilities
Non Current Assets Total	- 0.97	Other Liab
Property Plant And Equipment Gross	- 0.96	Other Liab
Other Stockholder Equity	- 0.96	Other Liab